Liquid Biopsies – News and Features
Mathematical Modeling Could Aid the Development of a Simple Blood Test for Brain Tumors
University of Bristol research could lead to better detection of the most common type of malignant brain cancer.
How a Tablespoon of Blood Could Transform Cancer Treatment
Researchers have developed a new blood test that provides unprecedented insight into a patient’s cancer make-up, potentially allowing doctors to better select treatment options that will improve outcomes.
Common Cancer Gene Regulates RNA “Dark Matter”
A new study has shown that a key genetic mutation that occurs early on in cancer alters RNA “dark matter” and causes the release of previously unknown RNA biomarkers.
New Marker Efficiently Detects Circulating Tumor Cells
UCF researchers have found a new way to track metastatic cancer cells in the body, which in the future could help identify cancer earlier and give patients more treatment options.
Highly Accurate, Non-Invasive Test for Major Liver Diseases Created
The liquid biopsy test, which uses two circulating proteins, was found to be highly accurate, sensitive and specific for both NASH and liver fibrosis.
Splice Variant Biomarkers Identified for Most Common Renal Cell Cancer
Researchers have identified biomarkers for clear cell renal cell carcinoma and have developed a tool to indicate which patients are at high risk of poor outcomes.
Liquid Biopsy Detects Breast Cancer DNA in Just Five Hours
Researchers have developed a novel, automated liquid biopsy test prototype, designed to detect cancer DNA in the blood of patients with advanced metastatic breast cancer within five hours.
Liquid Biopsies May Predict Response to Therapy for Esophageal Cancers
Researchers have developed a liquid biopsy that can effectively determine if a patient with esophageal cancer will respond to certain treatments, potentially avoiding patients receiving unnecessary additional therapy.
Blood Test Pinpoints Colon Cancer Patients Needing Chemotherapy
A novel blood test that assesses levels of circulating tumor DNA can identify patients who require chemo after surgery.
Liquid Biopsy Could Predict Lung Cancer Immunotherapy Success Better Than a Tumor Biopsy
A protein found in extracellular vesicles shed by tumor cells could be used as a liquid biopsy biomarker to better predict the success of immunotherapy for lung cancer patients.